LifeVantage (NASDAQ:LFVN) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of LifeVantage (NASDAQ:LFVNGet Rating) in a research report released on Monday morning. The firm issued a buy rating on the stock.

LifeVantage Trading Down 2.6 %

LFVN opened at $3.69 on Monday. The stock has a market capitalization of $46.32 million, a PE ratio of 15.38 and a beta of 1.22. LifeVantage has a 1-year low of $3.52 and a 1-year high of $7.70. The firm has a 50-day moving average price of $4.05 and a two-hundred day moving average price of $4.33.

LifeVantage Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, September 15th. Shareholders of record on Friday, September 2nd were given a $0.03 dividend. This represents a $0.12 annualized dividend and a yield of 3.25%. The ex-dividend date was Thursday, September 1st. LifeVantage’s payout ratio is presently 50.00%.

Institutional Investors Weigh In On LifeVantage

Several institutional investors have recently modified their holdings of the business. Victory Capital Management Inc. grew its position in shares of LifeVantage by 30.4% during the 1st quarter. Victory Capital Management Inc. now owns 13,868 shares of the company’s stock worth $66,000 after buying an additional 3,235 shares during the period. State Street Corp grew its position in shares of LifeVantage by 7.6% during the 1st quarter. State Street Corp now owns 46,191 shares of the company’s stock worth $220,000 after buying an additional 3,281 shares during the period. Renaissance Technologies LLC grew its position in shares of LifeVantage by 0.3% during the 2nd quarter. Renaissance Technologies LLC now owns 974,318 shares of the company’s stock worth $4,238,000 after buying an additional 3,300 shares during the period. O Shaughnessy Asset Management LLC grew its position in shares of LifeVantage by 49.8% during the 4th quarter. O Shaughnessy Asset Management LLC now owns 23,461 shares of the company’s stock worth $148,000 after buying an additional 7,804 shares during the period. Finally, American Century Companies Inc. grew its holdings in LifeVantage by 30.3% during the first quarter. American Century Companies Inc. now owns 46,016 shares of the company’s stock valued at $219,000 after purchasing an additional 10,706 shares during the period. Institutional investors and hedge funds own 27.06% of the company’s stock.

About LifeVantage

(Get Rating)

LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically validated dietary supplements; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support digestive system health; a line of weight management products under the PhysIQ brand; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a line of energy drink mixes.

Further Reading

Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.